<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000618582"><TermName>Nipent</TermName><TermPronunciation>(NY-pent)</TermPronunciation><TermDefinition><DefinitionText>The active ingredient in a drug that is used to treat hairy cell leukemia and is being studied in the treatment of other types of cancer. Nipent blocks a protein needed for cell growth and may kill cancer cells. It is made by a bacterium. It is a type of adenosine deaminase inhibitor. Also called pentostatin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000722504" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Nipent&quot;" language="en" id="_3"/><MediaLink ref="CDR0000722503" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Nipent&quot;" language="es" id="_4"/><SpanishTermName>Nipent</SpanishTermName><SpanishTermDefinition><DefinitionText>Ingrediente activo de un medicamento que se usa para tratar la leucemia de células pilosas y que está en estudio para el tratamiento de otros tipos de cáncer. Nipent bloquea una proteína que las células necesitan para crecer y podría destruir las células cancerosas. Es elaborado por una bacteria. Es un tipo de inhibidor de la desaminasa de adenosina. También se llama pentostatina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2008-10-28</DateFirstPublished><DateLastModified>2008-10-28</DateLastModified></GlossaryTerm>
